2 assets in Chemical Colitis

Therapeutic assets addressing Chemical Colitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Infliximab Chemical Colitis	Massachusetts General Hospital	P2	CCC (53)
Prednisone Chemical Colitis	Massachusetts General Hospital	P2	CCC (53)